查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760573

2025年介入性腫瘤消融市場報告

Interventional Tumor Ablation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

介入性腫瘤消融市場規模預計將在未來幾年強勁成長。 2029年，該市場規模將成長至24.9億美元，複合年成長率為8.6%。預測期內的成長可歸因於軟組織腫瘤和轉移性腫瘤發生率的上升、對個人化癌症治療策略的日益關注、對非手術腫瘤治療方案的需求不斷成長、轉向經濟高效的腫瘤治療方案，以及先進消融設備產品線的不斷拓展。預測期內預計的主要趨勢包括聯合治療的開發、混合燒灼術技術的研發、消融與數據分析的整合、腫瘤特異性奈米消融的創新以及消融系統技術的進步。

預計癌症盛行率的上升將在不久的將來顯著推動介入性腫瘤消融市場的成長。癌症是一組由體內異常細胞不受控制的生長和擴散所定義的疾病，這些細胞可侵入周圍組織並透過血液和淋巴系統轉移。癌症患者數量的增加主要是由於生活方式和環境因素，例如吸煙、不良飲食、肥胖和接觸致癌物質。介入性腫瘤消融透過提供微創技術改善了癌症治療，為患者提供了手術的替代方案。這些方法透過精確破壞腫瘤來縮短治療和恢復期，改善患者的預後和整體生活品質。例如，根據澳洲健康與福利研究所 2024 年 7 月的報告，預計到 2022 年澳洲的癌症診斷數量將增加到 160,570 例，比 2021 年的 156,781 例增加 3,789 例。癌症發生率的增加正在推動介入性腫瘤消融市場的擴張。

介入性腫瘤消融市場的主要企業正專注於開發先進的技術解決方案，例如 BioTrace 軟體套件，以提高腫瘤切除術的準確性和有效性。 BioTrace 軟體套件是一個整合工具，旨在追蹤、管理和分析生物數據，尤其是在醫療保健和研究環境中。例如，2024 年 7 月，以色列醫療設備 Technologies Ltd. 推出了 BioTraceIO Vision 和 BioTraceIO Precision 軟體套件，旨在增強影像導引的肝腫瘤消融治療。 BioTraceIO Vision 結合人工智慧 (AI) 驅動的工具進行個人化治療計劃和評估，以提高使用標準醫學影像的肝腫瘤消融程序的準確性和效率。同時，BioTraceIO Precision 在手術期間和手術後提供基於超音波的即時消融區域可視化和預測映射，幫助臨床醫生評估組織損傷和治療結果，並與消融後 24 小時的電腦斷層掃描高度相關。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球介入性腫瘤消融：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素及限制因素）
  • 最終用途產業分析
  • 全球介入性腫瘤消融市場：成長率分析
  • 全球介入性腫瘤消融市場表現：規模與成長，2019-2024
  • 全球介入性腫瘤消融市場預測：規模與成長，2024-2029，2034
  • 全球介入性腫瘤消融：總目標市場（TAM）

第6章市場區隔

  • 全球介入性腫瘤消融市場（依手術類型、績效及預測）2019-2024、2024-2029、2034
  • 開放性手術
  • 微創手術
  • 影像引導干預
  • 全球介入性腫瘤消融市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術（RFA）
  • 微波消融（MWA）
  • 冷凍療法
  • 雷射消熔
  • 高強度聚焦超音波（HIFU）
  • 全球介入性腫瘤消融市場（依設備類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 消融系統
  • 耗材
  • 支援的設備
  • 影像系統
  • 全球介入性腫瘤消融市場的應用、績效及預測（2019-2024、2024-2029、2034）
  • 肝臟腫瘤
  • 腎臟腫瘤
  • 肺腫瘤
  • 骨腫瘤
  • 全球介入性腫瘤消融市場（依最終用戶、績效及預測）2019-2024、2024-2029、2034
  • 醫院
  • 專門癌症治療中心
  • 門診手術中心
  • 研究所
  • 全球介入性腫瘤消融市場，依開放性手術類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 腹腔鏡腫瘤消融術
  • 開放性腫瘤切除術
  • 全球介入性腫瘤消融市場，依微創手術類型細分，績效及預測，2019-2024年，2024-2029年，2034年
  • 經皮腫瘤消融術
  • 內視鏡消融術
  • 全球介入性腫瘤消融市場，依影像導引介入類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • CT引導下腫瘤消融
  • 磁振造影引導腫瘤消融
  • 超音波引導下腫瘤消融

第7章 區域和國家分析

  • 全球介入性腫瘤消融市場各地區、績效及預測（2019-2024、2024-2029、2034）
  • 全球介入性腫瘤消融市場（依國家/地區、績效及預測）2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 介入性腫瘤消融市場：競爭格局
  • 介入性腫瘤消融市場：公司簡介
    • Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • EDAP TMS SA Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Boston Scientific Corporation
  • Olympus Corporation
  • Terumo Corporation
  • Hologic Inc.
  • Elekta
  • Conmed Corporation
  • Bioventus Inc.
  • AtriCure
  • AngioDynamics Inc.
  • Mermaid Medical Group A/S
  • InSightec
  • Cascination AG
  • HS Hospital Service SpA
  • Theraclion
  • IceCure Medical Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年介入性腫瘤消融市場：提供新機會的國家
  • 2029年介入性腫瘤消融市場：細分領域帶來新機會
  • 2029年介入性腫瘤消融市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35450

Interventional tumor ablation is a minimally invasive procedure that utilizes image-guided techniques to target and destroy cancerous or benign tumors without the need for open surgery. It uses thermal or non-thermal energy to eliminate tumor cells while minimizing damage to surrounding healthy tissue. This procedure is often employed when surgery is not viable or as an alternative to traditional treatments.

The main product types in interventional tumor ablation include open surgery, minimally invasive surgery, and image-guided interventions. Open surgery involves making an incision in the body to access and treat the affected area, typically using scalpels and other instruments. Key technologies in this field include radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, laser ablation, and high-intensity focused ultrasound (HIFU). Device types used in these procedures include ablation systems, consumables, support devices, and imaging systems. Tumor ablation is frequently applied to liver, kidney, lung, and bone tumors. The end users of these technologies range from hospitals and specialized cancer treatment centers to ambulatory surgical centers and research institutes.

The interventional tumor ablation market research report is one of a series of new reports from The Business Research Company that provides interventional tumor ablation market statistics, including the interventional tumor ablation industry's global market size, regional shares, competitors with the interventional tumor ablation market share, detailed interventional tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the interventional tumor ablation market. This interventional tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional tumor ablation market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the increasing prevalence of liver and kidney cancers, greater awareness of minimally invasive cancer treatments, enhanced availability of diagnostic imaging, a growing geriatric population more susceptible to tumors, and a rising preference for outpatient procedures.

The interventional tumor ablation market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be attributed to the rising incidence of soft tissue and metastatic tumors, an increasing focus on personalized cancer treatment strategies, growing demand for non-surgical tumor treatment options, a shift toward cost-effective tumor therapies, and an expanding pipeline of advanced ablation devices. Key trends expected in the forecast period include the development of combination therapies, the creation of hybrid ablation techniques, the integration of ablation with data analytics, innovations in tumor-specific nano-ablation, and advancements in ablation system technologies.

The increasing prevalence of cancer is expected to significantly boost the growth of the interventional tumor ablation market in the near future. Cancer, a group of diseases defined by the uncontrolled proliferation and spread of abnormal cells in the body, can invade surrounding tissues and potentially metastasize through the blood and lymphatic systems. The growing number of cancer cases is largely attributed to lifestyle and environmental factors such as smoking, poor diet, obesity, and exposure to carcinogens. Interventional tumor ablation improves cancer treatment by offering minimally invasive techniques, providing patients with an alternative to surgery. These methods shorten treatment time and recovery periods by allowing precise destruction of tumors, which improves patient outcomes and overall quality of life. For example, according to a July 2024 report from the Australian Institute of Health and Welfare, the number of cancer diagnoses in Australia increased to 160,570 in 2022, marking a rise of 3,789 cases from 156,781 in 2021. This growing cancer incidence is driving the expansion of the interventional tumor ablation market.

Leading companies in the interventional tumor ablation market are focusing on developing advanced technological solutions, such as the BioTrace software suite, to improve the precision and effectiveness of tumor ablation procedures. BioTrace software suites are integrated tools designed to track, manage, and analyze biological data, particularly in healthcare and research environments. For example, in July 2024, TechsoMed Medical Technologies Ltd., an Israel-based medical device company, introduced the BioTraceIO Vision and BioTraceIO Precision software suites, aimed at enhancing image-guided liver tumor ablation therapy. BioTraceIO Vision incorporates artificial intelligence (AI)-powered tools for personalized treatment planning and assessment, using standard medical imaging to boost the accuracy and efficiency of liver tumor ablation procedures. BioTraceIO Precision, on the other hand, provides real-time ultrasound-based visualization and predictive mapping of the ablation zone during and after the procedure, helping clinicians evaluate tissue damage and treatment outcomes with high correlation to 24-hour post-ablation CT scans.

In February 2024, Immunophotonics Inc., a US-based biotechnology company, formed a partnership with AngioDynamics Inc. This collaboration aims to combine Immunophotonics' leading immunotherapy asset, IP-001, with AngioDynamics' ablation devices to explore the potential of combining ablation with immunotherapy in treating solid tumor cancers. AngioDynamics Inc., a US-based medical device company, offers microwave and radiofrequency ablation technologies for minimally invasive cancer treatment.

Major players in the interventional tumor ablation market are Johnson And Johnson, EDAP TMS S.A., Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Hologic Inc., Elekta, Conmed Corporation, Bioventus Inc., AtriCure, AngioDynamics Inc., Mermaid Medical Group A/S, InSightec, Cascination AG, H.S. Hospital Service S.p.A, Theraclion, IceCure Medical Ltd.

North America was the largest region in the interventional tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional tumor ablation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional tumor ablation market consists of revenues earned by entities by providing services such as electroporation, tumor biopsy services, thermal ablation monitoring, and post-ablation follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional tumor ablation market also includes sales of radiofrequency ablation (RFA) generators, microwave ablation (MWA) systems, cryoablation probes, laser fibers and electrode needles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Tumor Ablation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional tumor ablation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional tumor ablation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure Type: Open Surgery; Minimally Invasive Surgery; Image-Guided Interventions
  • 2) By Technology: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)
  • 3) By Device Type: Ablation Systems; Consumables; Support Devices; Imaging Systems
  • 4) By Application Area: Liver Tumors; Kidney Tumors; Lung Tumors; Bone Tumors
  • 5) By End User: Hospitals; Specialized Cancer Treatment Centers; Ambulatory Surgical Centers; Research Institutes
  • Subsegments:
  • 1) By Open Surgery: Laparoscopic Tumor Ablation; Thoracotomy Tumor Ablation
  • 2) By Minimally Invasive Surgery: Percutaneous Tumor Ablation; Endoscopic Ablation
  • 3) By Image-Guided Interventions: Computed Tomography-Guided Tumor Ablation; Magnetic Resonance Imaging-Guided Tumor Ablation; Ultrasound-Guided Tumor Ablation
  • Companies Mentioned: Johnson And Johnson; EDAP TMS S.A.; Medtronic plc; Siemens Healthineers AG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Tumor Ablation Market Characteristics

3. Interventional Tumor Ablation Market Trends And Strategies

4. Interventional Tumor Ablation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Tumor Ablation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Tumor Ablation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Tumor Ablation Market Growth Rate Analysis
  • 5.4. Global Interventional Tumor Ablation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Tumor Ablation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Tumor Ablation Total Addressable Market (TAM)

6. Interventional Tumor Ablation Market Segmentation

  • 6.1. Global Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Surgery
  • Minimally Invasive Surgery
  • Image-Guided Interventions
  • 6.2. Global Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cryoablation
  • Laser Ablation
  • High-Intensity Focused Ultrasound (HIFU)
  • 6.3. Global Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ablation Systems
  • Consumables
  • Support Devices
  • Imaging Systems
  • 6.4. Global Interventional Tumor Ablation Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Tumors
  • Kidney Tumors
  • Lung Tumors
  • Bone Tumors
  • 6.5. Global Interventional Tumor Ablation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialized Cancer Treatment Centers
  • Ambulatory Surgical Centers
  • Research Institutes
  • 6.6. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Open Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laparoscopic Tumor Ablation
  • Thoracotomy Tumor Ablation
  • 6.7. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Minimally Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Percutaneous Tumor Ablation
  • Endoscopic Ablation
  • 6.8. Global Interventional Tumor Ablation Market, Sub-Segmentation Of Image-Guided Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Computed Tomography-Guided Tumor Ablation
  • Magnetic Resonance Imaging-Guided Tumor Ablation
  • Ultrasound-Guided Tumor Ablation

7. Interventional Tumor Ablation Market Regional And Country Analysis

  • 7.1. Global Interventional Tumor Ablation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Tumor Ablation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Tumor Ablation Market

  • 8.1. Asia-Pacific Interventional Tumor Ablation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Tumor Ablation Market

  • 9.1. China Interventional Tumor Ablation Market Overview
  • 9.2. China Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Tumor Ablation Market

  • 10.1. India Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Tumor Ablation Market

  • 11.1. Japan Interventional Tumor Ablation Market Overview
  • 11.2. Japan Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Tumor Ablation Market

  • 12.1. Australia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Tumor Ablation Market

  • 13.1. Indonesia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Tumor Ablation Market

  • 14.1. South Korea Interventional Tumor Ablation Market Overview
  • 14.2. South Korea Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Tumor Ablation Market

  • 15.1. Western Europe Interventional Tumor Ablation Market Overview
  • 15.2. Western Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Tumor Ablation Market

  • 16.1. UK Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Tumor Ablation Market

  • 17.1. Germany Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Tumor Ablation Market

  • 18.1. France Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Tumor Ablation Market

  • 19.1. Italy Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Tumor Ablation Market

  • 20.1. Spain Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Tumor Ablation Market

  • 21.1. Eastern Europe Interventional Tumor Ablation Market Overview
  • 21.2. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Tumor Ablation Market

  • 22.1. Russia Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Tumor Ablation Market

  • 23.1. North America Interventional Tumor Ablation Market Overview
  • 23.2. North America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Tumor Ablation Market

  • 24.1. USA Interventional Tumor Ablation Market Overview
  • 24.2. USA Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Tumor Ablation Market

  • 25.1. Canada Interventional Tumor Ablation Market Overview
  • 25.2. Canada Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Tumor Ablation Market

  • 26.1. South America Interventional Tumor Ablation Market Overview
  • 26.2. South America Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Tumor Ablation Market

  • 27.1. Brazil Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Tumor Ablation Market

  • 28.1. Middle East Interventional Tumor Ablation Market Overview
  • 28.2. Middle East Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Tumor Ablation Market

  • 29.1. Africa Interventional Tumor Ablation Market Overview
  • 29.2. Africa Interventional Tumor Ablation Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Tumor Ablation Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Tumor Ablation Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Tumor Ablation Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Tumor Ablation Market Competitive Landscape
  • 30.2. Interventional Tumor Ablation Market Company Profiles
    • 30.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. EDAP TMS S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Tumor Ablation Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Olympus Corporation
  • 31.3. Terumo Corporation
  • 31.4. Hologic Inc.
  • 31.5. Elekta
  • 31.6. Conmed Corporation
  • 31.7. Bioventus Inc.
  • 31.8. AtriCure
  • 31.9. AngioDynamics Inc.
  • 31.10. Mermaid Medical Group A/S
  • 31.11. InSightec
  • 31.12. Cascination AG
  • 31.13. H.S. Hospital Service S.p.A
  • 31.14. Theraclion
  • 31.15. IceCure Medical Ltd.

32. Global Interventional Tumor Ablation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Tumor Ablation Market

34. Recent Developments In The Interventional Tumor Ablation Market

35. Interventional Tumor Ablation Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Tumor Ablation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Tumor Ablation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Tumor Ablation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer